Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR2554 in relapsed/refractory follicular lymphoma (single-arm phase II)
CTR20241185Phase 2Active
- Sponsor
- Hengrui Therapeutics
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zeprumetostat in follicular lymphoma (FL), sponsored by Hengrui Therapeutics. Started Apr 2024; status: active.
02
Drugs
zeprumetostat
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on CTR20241185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241185.